Clinical Use of Magnetic Resonance Imaging Across the Prostate Brachytherapy Workflow

Overview

Journal Brachytherapy

Specialty Radiology

Date 2017 Feb 4

PMID 28153700

Citations 6

Authors

P Blanchard

C Menard

S J Frank

Affiliations

Soon will be listed here.

Abstract

MRI produces better soft tissue contrast than does ultrasonography or computed tomography for visualizing male pelvic anatomy and prostate cancer. Better visualization of the tumor and organs at risk could allow better conformation of the dose to the target volumes while at the same time minimizing the dose to critical structures and the associated toxicity. Although the use of MRI for prostate brachytherapy would theoretically result in an improved therapeutic ratio, its implementation been slow, mostly because of technical challenges. In this review, we describe the potential role of MRI at different steps in the treatment workflow for prostate brachytherapy: for patient selection, treatment planning, in the operating room, or for postimplant assessment. We further present the current clinical experience with MRI-guided prostate brachytherapy, both for permanent seed implantation and high-dose-rate brachytherapy.

Citing Articles

A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation Therapy.

Wang L, Sanders J, Ward J, Lee S, Poenisch F, Swanson D Cancers (Basel). 2024; 16(3).

PMID: 38339376 PMC: 10854757. DOI: 10.3390/cancers16030625.

MRI-TRUS registration methodology for TRUS-guided HDR prostate brachytherapy.

McGeachy P, Watt E, Husain S, Martell K, Martinez P, Sawhney S J Appl Clin Med Phys. 2021; 22(8):284-294.

PMID: 34318581 PMC: 8364261. DOI: 10.1002/acm2.13292.

Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy.

Bathala T, Venkatesan A, Ma J, Bhosale P, Wei W, Kudchadker R Brachytherapy. 2020; 19(4):484-490.

PMID: 32402544 PMC: 7368804. DOI: 10.1016/j.brachy.2020.04.001.

Addition of magnetic resonance imaging to real time trans-rectal ultrasound-based treatment planning for prostate implants.

Petronek M, Balik S, Purysko A, Klein E, Ciezki J, Wilkinson A J Contemp Brachytherapy. 2019; 11(4):361-369.

PMID: 31523238 PMC: 6737565. DOI: 10.5114/jcb.2019.87189.

Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging/computed tomography fusion image-based post-implant dosimetry of prostate brachytherapy.

Watanabe K, Katayama N, Katsui K, Matsushita T, Takamoto A, Ihara H J Radiat Res. 2019; 60(4):483-489.

PMID: 31083713 PMC: 6640899. DOI: 10.1093/jrr/rrz012.

References

Davis B, Horwitz E, Lee W, Crook J, Stock R, Merrick G . American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy. 2012; 11(1):6-19. DOI: 10.1016/j.brachy.2011.07.005. View

King M, Nasser N, Mathur N, Cohen G, Kollmeier M, Yuen J . Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapy. Brachytherapy. 2016; 15(3):266-273. PMC: 5546833. DOI: 10.1016/j.brachy.2016.02.003. View

Crook J, McLean M, Yeung I, Williams T, Lockwood G . MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy. Brachytherapy. 2004; 3(2):55-60. DOI: 10.1016/j.brachy.2004.05.001. View

Buus S, Rylander S, Hokland S, Sondergaard C, Pedersen E, Tanderup K . Learning curve of MRI-based planning for high-dose-rate brachytherapy for prostate cancer. Brachytherapy. 2016; 15(4):426-434. DOI: 10.1016/j.brachy.2016.03.011. View

Cornud F, Flam T, Chauveinc L, Hamida K, Chretien Y, Vieillefond A . Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology. 2002; 224(1):203-10. DOI: 10.1148/radiol.2241011001. View

Lee J, Spratt D, Liss A, McLaughlin P . Vessel-sparing radiation and functional anatomy-based preservation for erectile function after prostate radiotherapy. Lancet Oncol. 2016; 17(5):e198-208. DOI: 10.1016/S1470-2045(16)00063-2. View

Cormack R, Tempany C, DAmico A . Optimizing target coverage by dosimetric feedback during prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000; 48(4):1245-9. DOI: 10.1016/s0360-3016(00)00742-2. View

Foltz W, Porter D, Simeonov A, Aleong A, Jaffray D, Chung P . Readout-segmented echo-planar diffusion-weighted imaging improves geometric performance for image-guided radiation therapy of pelvic tumors. Radiother Oncol. 2015; 117(3):525-31. DOI: 10.1016/j.radonc.2015.07.046. View

DiBiase S, Hosseinzadeh K, Gullapalli R, Jacobs S, Naslund M, Sklar G . Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2002; 52(2):429-38. DOI: 10.1016/s0360-3016(01)02609-8. View

10.

Peach M, Trifiletti D, Libby B . Systematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion. Prostate Cancer. 2016; 2016:4754031. PMC: 4884850. DOI: 10.1155/2016/4754031. View

11.

Albert M, Tempany C, Schultz D, Chen M, Cormack R, Kumar S . Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer. 2003; 98(5):949-54. DOI: 10.1002/cncr.11595. View

12.

DAmico A, Tempany C, Schultz D, Cormack R, Hurwitz M, Beard C . Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology. 2003; 62(6):1063-7. DOI: 10.1016/s0090-4295(03)00772-6. View

13.

DAmico A, Cormack R, Tempany C, Kumar S, Topulos G, Kooy H . Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1998; 42(3):507-15. DOI: 10.1016/s0360-3016(98)00271-5. View

14.

Albert J, Swanson D, Pugh T, Zhang M, Bruno T, Kudchadker R . Magnetic resonance imaging-based treatment planning for prostate brachytherapy. Brachytherapy. 2012; 12(1):30-7. DOI: 10.1016/j.brachy.2012.03.009. View

15.

Murgic J, Chung P, Berlin A, Bayley A, Warde P, Catton C . Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer. Brachytherapy. 2016; 15(2):147-55. DOI: 10.1016/j.brachy.2015.12.004. View

16.

Nguyen P, Chen M, Zhang Y, Tempany C, Cormack R, Beard C . Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy. J Urol. 2012; 188(4):1151-6. PMC: 3744091. DOI: 10.1016/j.juro.2012.06.010. View

17.

Lim T, Kudchadker R, Wang J, Bathala T, Szklaruk J, Pugh T . Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience. J Contemp Brachytherapy. 2016; 8(3):235-42. PMC: 4965498. DOI: 10.5114/jcb.2016.60506. View

18.

Schick U, Popowski Y, Nouet P, Bieri S, Rouzaud M, Khan H . High-dose-rate brachytherapy boost to the dominant intra-prostatic tumor region: hemi-irradiation of prostate cancer. Prostate. 2011; 71(12):1309-16. DOI: 10.1002/pros.21347. View

19.

Barentsz J, Weinreb J, Verma S, Thoeny H, Tempany C, Shtern F . Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol. 2015; 69(1):41-9. PMC: 6364687. DOI: 10.1016/j.eururo.2015.08.038. View

20.

Register S, Kudchadker R, Levy L, Swanson D, Pugh T, Bruno T . An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trial. Brachytherapy. 2013; 12(3):210-6. PMC: 3891368. DOI: 10.1016/j.brachy.2012.10.006. View